Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 13, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2018. Go to the latest filing (Q3 2026)

11.1B USDQ4 2018
Total value of stock positions
11.1B USD
Positions
35
Share of the ten largest
75.3%

The ten largest positions Q4 2018

  1. Twenty First Centy Fox Inc 22.2%▼ −1.4%
  2. Cheniere Energy Inc 7.6%unchanged
  3. Twenty First Centy Fox Inc 7.3%▼ −1.6%
  4. Viasat Inc 7.3%unchanged
  5. Qorvo Inc 5.8%▼ −2.9%
  6. Allergan PLC 5.7%▼ −3.9%
  7. Liberty Global PLC 5.5%▲ +176.2%
  8. Pioneer Nat Res Co 5.3%▲ +12.5%
  9. eBay Inc. 5.3%new
  10. PG&E Corporation 3.3%▼ −18.5%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q4 2018

Positions Q4 2018 per 13F filing, 10 of 10
Symbol Weight Shares Reported value Change Held since
Twenty First Centy Fox Inc 22.2% 51,281,167 2.5B USD −1.4% reduced Q3 2015 14 quarters
Twenty First Centy Fox Inc 7.3% 17,040,922 814.2M USD −1.6% reduced Q3 2015 14 quarters
Qorvo Inc 5.8% 10,681,181 648.7M USD −2.9% reduced Q1 2017 8 quarters
Allergan PLC 5.7% 4,755,495 635.6M USD −3.9% reduced Q1 2016 12 quarters
PCG PG&E Corporation 3.3% 15,474,483 367.5M USD −18.5% reduced Q1 2018 4 quarters
SYF Synchrony Financial 3.1% 14,553,557 341.4M USD −10.9% reduced Q3 2016 10 quarters
MCK McKesson Corporation 1.7% 1,720,011 190.0M USD −20.9% reduced Q3 2017 6 quarters
COR Cencora 1.3% 2,014,299 149.9M USD −26.8% reduced Q3 2017 6 quarters
CAH Cardinal Health 0.6% 1,467,652 65.5M USD −69.0% reduced Q4 2016 9 quarters
AMC AMC Entertainment 0.2% 1,458,002 17.9M USD −46.6% reduced Q3 2017 6 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 395.0M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Tesla Inc principal 300.0M USD 364.1M USD
  • Theravance Biopharma Inc principal 30.0M USD 30.9M USD

Breakdown by sector

  • Consumer Discretionary 5.3%
  • Health Care 3.6%
  • Utilities 3.3%
  • Financials 3.1%
  • Communication Services 0.2%
  • not in our coverage 84.5%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close